| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Tobramycin^peak post extended interval dosing | LP308039-9 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Tobramycin | Serum or Plasma | Drug toxicology | LP389051-6 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | mg/L;mcg/mL | |
| EXAMPLE_UCUM_UNITS | mg/L | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
| LONG_COMMON_NAME | en-US | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
| SHORTNAME | en-US | Tobramycin Pk EID SerPl-mCnc |
| ConsumerName | en-US | Tobramycin Peak after Extended Interval Dosing, Blood |
| SHORTNAME | es-AR | tobramicina^pico después de intervalo de dosificación extendido:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: |
| SHORTNAME | pt-BR | Tobramycin Pk EID SerPl-mCnc |
| LONG_COMMON_NAME | fr-FR | Tobramycine pic après un intervalle posologique allongé [Masse/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Tobramycine^piek na langdurige intervaldosering [massa/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Tobramicina : Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.80
FHIR